Investor insights
Sectors invested in
Funding rounds participated in
$45M sweet spot round size
Most of their 33 investments are in rounds between $35M and $87M
Investor type
Basic info
Industry
Sectors
Date founded
2012
Investments made
Undisclosed raised $121M on June 12, 2023
Investors: Oxford Sciences Innovation and Syncona Limited
Mosaic TX raised $28M on April 4, 2023
Investors: Cambridge Innovation Capital plc and Syncona Limited
SwanBio Therapeutics raised $56M on May 18, 2022
Investors: Syncona Limited
OMass Therapeutics raised $95M on April 27, 2022
Investors: Sanofi Ventures, Oxford Sciences Innovation, Northpond Ventures, University of Oxford, GV and Syncona Limited
Freeline raised $26M on March 10, 2022
Investors: Syncona Limited
ANAVEON AG raised $119M on December 16, 2021
Investors: Forbion, Pontifax Venture Capital and Syncona Limited
Quell Therapeutics raised $156M on November 29, 2021
Investors: SV Life Sciences, Tekla Capital Management, Monashee Investment Management LLC, JEITO, British Patient Capital, Ridgeback Capital Management LLC, Point72 Asset Management and Syncona Limited
Clade Therapeutics raised $87M on November 3, 2021
Investors: LifeSci Venture Partners, Bristol-Myers Squibb, UK, Emerson Collective and Syncona Limited
Gyroscope Therapeutics raised $149M on March 26, 2021
Investors: Tetragon Financial Group Limited, Forbion, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Cambridge Innovation Capital plc, Fosun Pharma and Syncona Limited
Quell Therapeutics raised $40M on February 11, 2021
Investors: UCL Technology Fund and Syncona Limited